Boundless Share Price

Boundless Share Price

NASDAQ: BOLD | Micro Cap | Healthcare
$2.40
-$0.01 (-0.41%) Last updated on 19 Nov, 2026 | 00:48 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Boundless Stock Performance

Open
$2.40
Prev. Close
$2.41
Circuit Range
N/A
Day Range
$2.40 - $2.40
Year Range
$0.98 - $3.12
Volume
785
Average Traded
$2.40

Boundless Share Price Today

As of 19 November 2026, Boundless Bio, Inc.'s share price is $2.40. The stock opened at $2.40, compared to its previous close of $2.41. During today's trading session, Boundless Bio, Inc.'s share price traded between $2.40 and $2.40, with an average price of $2.40. Over the past 52 weeks, the stock has recorded a high of $3.12 and a low of $0.98. In terms of performance, Boundless Bio, Inc.'s share price has risen by 64.38% over the last six months and is up 107.79% on a year-on-year basis.

Boundless Share Price Chart

Line chart of the Boundless price trend over the selected period. The price fell overall, ranging from 2.40 to 2.42, ending at 2.40.
$2.40$2.40
L
Show Current Price
H

Boundless Stock Fundamentals & Key Indicators

Market Cap
$53.66M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.35
Revenue (TTM)
$0.00
Return On Equity (TTM)
-89.91%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
58.42%

Boundless Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$12.89-$13.56-$23.69-$5.36
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-5.20%-74.71%77.37%

Boundless Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$65.36-$58.20
Net Profit MarginN/AN/A
Income ChangeN/A10.95%

Boundless Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets47.4552.02
Current Assets109.61154.39
Total Assets157.06206.41
Non Current Liabilities45.8747.63
Current Liabilities12.548.14
Total Liabilities58.4155.77
Shareholders' Equity98.65150.64

Boundless Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-46.66-60.84
Investing37.8-26.1
Financing0.1489.82

About Boundless

Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.

Boundless Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.50
$2.40
-1.44%
Oct 2026
$2.59
$2.44
-1.62%
Sep 2026
$2.81
$2.48
-14.06%
Aug 2026
$2.51
$2.88
+15.66%
Jul 2026
$2.50
$2.49
-0.60%
Jun 2026
$1.46
$2.50
+71.58%
May 2026
$1.51
$1.46
+0.34%
Apr 2026
$1.14
$1.46
+31.08%
Mar 2026
$1.13
$1.11
-4.31%
Feb 2026
$1.14
$1.16
+0.87%
Jan 2026
$1.22
$1.15
-3.36%
Dec 2025
$1.17
$1.19
+3.03%

Boundless Share Price FAQs